Single User License: $2750
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
The global market for nanobiotechnology should grow from $38.5 billion in 2021 to $68.4 billion by 2026, at compound annual growth rate (CAGR) of 12.2% for the period of 2021-2026.
Report Includes
- 105 tables
- An updated review of the global market for nanobiotechnology applications
- Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Estimation of the market size and market forecast for nanobiotechnology applications, and corresponding market share analysis by molecular diagnostic application, therapeutic application, biopharmaceutical application, and geography
- Highlights of key market dynamics, issues and trends, gaps and opportunities influencing current and future demand for nanobiotechnology in the global market and its sub-segments
- Regional outlook and a country level assessment of nanobiotechnology applications market considering all macroeconomic factors, and Covid-19 impact analysis within the industry
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
- Discussion of major market segments and their respective technologies in the overall global market for nanobiotechnology
- Assessment of major stakeholders and analysis of the key competitive landscape based on recent developments and segmental revenues
- Profile descriptions of the leading industry players including Ablynx, Arrowhead Pharmaceuticals Inc., Celgene Corp., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Bio-Gate AG, Nanophase Technologies Corp., and Starpharma Holdings Ltd.
Report Scope
The scope of this investigation includes the major viable nanobiotechnologies that are currently being implemented in various industries. The study scope includes the major nanotechnology formats that willor likely to become commercialized within the next 5 years. Each technology format is analyzed to determine its market status, impact on future market segments and forecasted growth from 2021 through 2026. Technology issues and market-driving forces are discussed. Influencing factors, including drug delivery needs, biologic imaging trends and industry structure, are also discussed. BCC Research examines nanobiotechnology companies and industry alliances, nanomaterial consumption, end-user industry, and market-driving forces.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Bio-based Composite Material Market (AVM232B)
- Global Markets for 3D Printing (MFG074C)
- Global Single-cell Technologies Market (BIO257A)
- Artificial Intelligence (AI) in Life Sciences Market (BIO255A)
- Silicones: Global Markets (AVM207B)
Report Highlights
The total market for nanobiotechnology products is $19.3 billion in 2010 and is growing at a compound annual growth rate (CAGR) of 9% to reach a forecast market size of $29.7 billion by 2015.
Related Reports
Global Markets and Technologies for Nanofibers
The global market for nanofibers is estimated to increase from $2.9 billion in 2023 to reach $9.4 billion by 2028, at a compound annual growth rate (CAGR) of 26.0% from 2023 through 2028.
Nanomaterials in Personalized Medicine: Global Markets
The global market for nanomaterials in personalized medicine is expected to increase from $346.7 billion in 2023 to $592.0 billion by the end of 2028, with a compound annual growth rate (CAGR) of 11.3% during the forecast period of 2023-2028.
Global Nanotechnology Market
The global market for nanotechnology is estimated to increase from $68.0 billion in 2023 to reach $183.7 billion by 2028, at a compound annual growth rate (CAGR) of 22.0% from 2023 through 2028.
Nanotechnology in Medical Applications: The Global Market
The global market for nanomedicine should grow from $242.6 billion in 2021 to $493.5 billion by 2026 with a compound annual growth rate (CAGR) of 15.3% for the period of 2021-2026.
Recent Reports
Global Markets and Technologies for Nanofibers
The global market for nanofibers is estimated to increase from $2.9 billion in 2023 to reach $9.4 billion by 2028, at a compound annual growth rate (CAGR) of 26.0% from 2023 through 2028.
Global Nanotechnology Market
The global market for nanotechnology is estimated to increase from $68.0 billion in 2023 to reach $183.7 billion by 2028, at a compound annual growth rate (CAGR) of 22.0% from 2023 through 2028.
Nanotechnology in Energy Applications
The global nanotechnology in energy applications market should reach $18.8 billion by 2028 from $9.3 billion in 2023 at a compound annual growth rate (CAGR) of 15.0% for the forecast period of 2023 to 2028.
Lead-Free Piezoelectric Ceramics: Technologies and Global Opportunities
The global market for lead-free piezoelectric ceramics should grow from $184.1 million in 2021 to $402.1 million by 2026, at compound annual growth rate (CAGR) of 16.9% for the period of 2021-2026.
Global Markets and Technologies for Nanofibers
The global market for nanofiber should grow from $2.2 billion in 2021 to $6.7 billion by 2026 with a compound annual growth rate (CAGR) of 25.1% for the period of 2021-2026.
Top Trending Reports
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Wearable Medical Devices: Technologies and Global Markets
The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.
Carbon Credits Market: Global Outlook
This report provides an up-to-date analysis of current and future markets for carbon credits and the carbon offsets industry. It presents a thorough and up-to-date global assessment of the market and business of carbon credits. The report also includes a competitive landscape, ESG analysis, and detailed company profiles of leading market players.
Biodegradable Polymers: Global Markets and Technologies
The global market volumes of biodegradable polymers is expected to grow from 1,286.0 kilotons in 2023 and is projected to reach 4,140.0 kilotons by the end of 2028, at a compound annual growth rate (CAGR) of 26.3% during the forecast period of 2023 to 2028.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More